Hotline: 1800 102 2007
Hotline: 1800 102 2007
Feb, 24 2017

Zydus gets USFDA nod for phase II trials of liver drug

Zydus Cadila Chairman and MD Pankaj R Patel said: "We are very thankful to the USFDA for their timely and useful feedback on the clinical trial designs of Saroglitazar Mg in patients with PBC."

Zydus gets USFDA nod for phase II trials of liver drug

Drug firm Zydus Cadila has said the US health regulator has approved the group's plans to initiate phase II clinical trials of Saroglitazar Magnesium in patients suffering from a certain liver disease.

In a statement, Zydus Cadila, said, "The United States Food and Drug Administration (USFDA) has approved the group's plans to initiate a phase II clinical trial of Saroglitazar Magnesium (Mg) in patients with primary biliary cholangitis (PBC) of the liver."

This trial will evaluate Saroglitazar Magnesium 2mg and 4mg vs Placebo, it added.

Zydus Cadila Chairman and MD Pankaj R Patel said: "We are very thankful to the USFDA for their timely and useful feedback on the clinical trial designs of Saroglitazar Mg in patients with PBC."

This development underlines the group's commitment to bridging unmet healthcare needs with innovative therapies, he added.

Primary Biliary Cholangitis is a liver disease, caused due to progressive destruction of the bile ducts in the liver which leads to reduction of bile flow - a condition referred to as cholestasis, Zydus Cadila said.

Progression of PBC leads to symptoms of cirrhosis like yellowing of the skin, swelling of legs and feet, ascites, internal bleeding and thinning of the bones, it added.

Shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 430.50 per scrip on BSE, down 0.93 per cent from its previous close.

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • Casual Dine Restaurants
    About Us: Mamu’s Infusion is a highly-popular and renowned fine dine..
    Locations looking for expansion Rajasthan
    Establishment year 1990
    Franchising Launch Date 2017
    Investment size Rs. 50lac - 1 Cr.
    Space required 150
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Jaipur Rajasthan
  • Others
    Humsafar is a consumer brand of “Samridhi Highway Solutions Pvt Ltd” wh..
    Locations looking for expansion Haryana
    Establishment year 2016
    Franchising Launch Date 2020
    Investment size Rs. 30lac - 50lac
    Space required -NA-
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Gurgaon Haryana
  • Quick Service Restaurants
    The Journey started in 1984…It all began with a dream..
    Locations looking for expansion Maharashtra
    Establishment year 1984
    Franchising Launch Date 2021
    Investment size Rs. 5lac - 10lac
    Space required 350
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater pune Maharashtra
  • Healthcare & Medical Products
    About Us: Hippnation started as India’s first online powered brand and..
    Locations looking for expansion Delhi
    Establishment year 2020
    Franchising Launch Date 2016
    Investment size Rs. 10000 - 50000
    Space required 150
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquater New delhi Delhi
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities